KLKB1抗体,Rabbit Monoclonal KLKB1 Antibody
  • KLKB1抗体,Rabbit Monoclonal KLKB1 Antibody
  • KLKB1抗体,Rabbit Monoclonal KLKB1 Antibody
  • KLKB1抗体,Rabbit Monoclonal KLKB1 Antibody

KLKB1抗体;KLKB1 Antibody—艾普蒂

价格 询价
包装 20μl 50μl 100μl
最小起订量 1μl
发货地 上海
更新日期 2025-05-29
QQ交谈 微信洽谈

产品详情

中文名称:KLKB1抗体英文名称:Rabbit Monoclonal KLKB1 Antibody
品牌: 艾普蒂产地: 武汉
保存条件: Stored at -20°C for 8142 year. Avoid repeated freeze / thaw cycles.产品类别: 抗体
重组: 应用: WB: IHC-P: IHC-F: ICC/IF: IP:FC:ChIP: ELISA
种属反应性: Human,Mouse,Rat 宿主: Rabbit
偶联物: 靶点: KLKB1
2025-05-29 KLKB1抗体 Rabbit Monoclonal KLKB1 Antibody 20μl/RMB;50μl/RMB;100μl/RMB 艾普蒂 武汉 Stored at -20°C for 8142 year. Avoid repeated freeze / thaw cycles. 抗体

验证与应用

应用及物种
WB咨询技术 Human,Mouse,Rat
IF1/20-1/50 Human,Mouse,Rat
IHC1/100-1/200 Human,Mouse,Rat
ICC技术咨询 Human,Mouse,Rat
FCM咨询技术 Human,Mouse,Rat
Elisa咨询技术 Human,Mouse,Rat
   

产品详情

AliasesFletcher factor; kallikrein B plasma; Kallikrein B1; Kininogenin; KLK3; KLKB1; PKK; PKKD; Plasma kallikrein light chain; PPK; Prekallikrein; ;Plasma kallikrein
WB Predicted band sizeCalculated MW: 71 kDa ; Observed MW: 80 kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman,Rat
ImmunogenA synthesized peptide derived from human Plasma kallikrein
FormulationPurified antibody in PBS with 0.05% sodium azide,0.05% BSA and 50% glycerol.

+ +

  •  

     

       Western blot analysis of KLKB1 expression in human plasma lysate.    


           

参考文献

以下是关于KLKB1抗体的假设性参考文献示例,供参考(注:文献信息为模拟,实际引用需核实):

1. **标题**:*Targeting Plasma Kallikrein with Monoclonal Antibodies for Hereditary Angioedema Therapy*

**作者**:Zuraw, B.L. et al.

**摘要**:研究报道开发了针对KLKB1的单克隆抗体,通过抑制血浆激肽释放酶活性,显著减少遗传性血管性水肿患者的缓激肽生成,为靶向治疗提供了新策略。

2. **标题**:*Role of KLKB1 in Coagulation and Inflammation: Insights from Antibody-Based Inhibition*

**作者**:Schmaier, A.H. et al.

**摘要**:利用KLKB1特异性抗体阻断其功能,揭示了该蛋白在接触激活凝血通路和炎症反应中的双重作用,为血栓性疾病机制研究提供依据。

3. **标题**:*KLKB1 as a Biomarker in Cardiovascular Disease: Validation via Immunoassay*

**作者**:Prisco, N. et al.

**摘要**:通过酶联免疫吸附试验(ELISA)结合KLKB1抗体,发现血浆中KLKB1水平与动脉粥样硬化严重程度呈正相关,提示其作为心血管风险的潜在标志物。

4. **标题**:*Structural Characterization of KLKB1 Using Polyclonal Antibodies for Epitope Mapping*

**作者**:López-Trascasa, M. et al.

**摘要**:通过多克隆抗体识别KLKB1的抗原表位,解析其三维结构关键区域,为开发高特异性抑制剂奠定基础。

建议通过数据库(如PubMed、Web of Science)以“KLKB1 antibody”或“plasma kallikrein inhibitor”为关键词检索最新文献,以获取真实研究数据。

       

背景信息

KLKB1 antibodies target the plasma kallikrein enzyme, encoded by the *KLKB1* gene, which plays a critical role in the kallikrein-kinin system (KKS). This serine protease regulates inflammatory responses, blood pressure, coagulation, and fibrinolysis by cleaving kininogens to release vasoactive kinins, such as bradykinin. Dysregulation of KLKB1 activity is implicated in hereditary angioedema (HAE), diabetic complications, hypertension, and thrombosis, making it a therapeutic and diagnostic focus.

KLKB1 antibodies are essential tools for studying the enzyme's expression, localization, and function in physiological and pathological contexts. They are used in techniques like Western blotting, immunohistochemistry, and ELISA to quantify KLKB1 levels in tissues or biofluids. Therapeutic antibodies or inhibitory peptides targeting KLKB1 are under investigation to block excessive kinin production in HAE or inflammation-driven diseases. Additionally, these antibodies aid in exploring KLKB1's interactions with inhibitors (e.g., C1 esterase inhibitor) or its role in cross-activating coagulation Factor XII.

Most KLKB1 antibodies are produced in rabbits or mice using recombinant KLKB1 protein fragments. Specificity and cross-reactivity validation are crucial due to structural similarities among kallikrein family proteases. Advances in recombinant antibody engineering have improved their clinical applicability, including diagnostics for kallikrein-related disorders and monitoring treatment efficacy in trials targeting the KKS pathway.

       
关键字: KLKB1抗体;KLKB1;KLKB1 Antibody;

公司简介

生物技术有限公司
成立日期 2024-07-02 (2年) 注册资本 20万人民币
员工人数 1-10人 年营业额 ¥ 100万以内
主营行业 抗体,植物生物技术,细胞培养,蛋白组学 经营模式 贸易,工厂,试剂,定制,服务
  • 上海切尔齐生物科技有限公司
VIP 1年
  • 公司成立:2年
  • 注册资本:20万人民币
  • 企业类型:有限责任公司(自然人投资或控股)
  • 主营产品:生物试剂
  • 公司地址:青浦
询盘

KLKB1抗体;KLKB1 Antibody—艾普蒂相关厂家报价

产品名称 价格   公司名称 报价日期
询价
VIP3年
武汉佰乐博生物技术有限公司
2025-07-24
¥1950
VIP3年
上海沪震实业有限公司
2025-07-23
¥1800
VIP1年
费雪(杭州)医学研究有限公司
2025-07-14
内容声明:
以上所展示的信息由商家自行提供,内容的真实性、准确性和合法性由发布商家负责。 商家发布价格指该商品的参考价格,并非原价,该价格可能随着市场变化,或是由于您购买数量不同或所选规格不同而发生变化。最终成交价格,请咨询商家,以实际成交价格为准。请意识到互联网交易中的风险是客观存在的
主页 | 企业会员服务 | 广告业务 | 联系我们 | 旧版入口 | 中文MSDS | CAS Index | 常用化学品CAS列表 | 化工产品目录 | 新产品列表 |投诉中心
Copyright © 2008 ChemicalBook 京ICP备07040585号  京公海网安备110108000080号  All rights reserved.